EQS-News

SINGULUS TECHNOLOGIES Reports Key Financial Figures for the Group for Q1 2024

EQS-News: SINGULUS TECHNOLOGIES AG / Key word(s): Quarter Results SINGULUS TECHNOLOGIES Reports Key Financial Figures for the Group for Q1 2024 15.05.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release

SINGULUS TECHNOLOGIES Reports Key Financial Figures for the Group for Q1 2024

• Key financial figures Q 1-2024 positive
• Gross margin at 29.4 %
• Outlook for 2024 positive
   

Kahl am Main, May 15, 2024 - SINGULUS TECHNOLOGIES reports key financial figures for the Group for the first quarter of 2024. The order intake increased to € 33.2 million in the first quarter of 2024 and was thus significantly above the previous year's level of € 14.1 million. Incoming orders are spread across all of the company's segments, although it should be emphasized that the Semiconductor segment recorded the highest order intake and further orders are expected here in the coming months. The order backlog amounted to € 71.6 million as of March 31, 2024 (previous year: € 82.6 million).

Revenue amounted to € 20.6 million in the quarter under review, up on the previous year's figure of € 16.3 million. At € 0.6 million (previous year: € -0.9 million), earnings before interest and taxes (EBIT) improved compared to the previous year and were slightly positive. SINGULUS TECHNOLOGIES' freely available liquidity amounted to € 6.3 million as of March 31, 2024, compared to € 11.5 million as of December 31, 2023. December 31, 2023. In the first quarter of 2024, the gross margin reached 29.4 %, as in the 29.4% in the previous year.

Dr. Stefan Rinck, CEO of SINGULUS TECHNOLOGIES: "We are working intensively to open up new markets with promising growth potential." Dr. Rinck continues: "We are focusing on markets in which our systems give us a unique position compared to our competitors and create high added value for our customers. We have therefore expanded our product range with coating systems for hydrogen and battery technology applications."